Al Laham Omar, Atia Fareed, Ibrahim Dana, Shaheen Jack, Hokouk Bashir
Department of Surgery, Al-Mouwasat University Hospital, Damascus, Syria; Department of Surgery, Al Assad University Hospital, Damascus, Syria.
Tishreen University, Lattakia, Syria.
Int J Surg Case Rep. 2022 Jul;96:107367. doi: 10.1016/j.ijscr.2022.107367. Epub 2022 Jun 30.
Synchronous malignancies are defined as the emergence of one or more tumors which either occur simultaneously or within 6 months of each other. Populations older than 50 years of age are the most vulnerable. Documented prevalence rates of synchronous neoplasia are 4.5-11.7 %. To the best of our knowledge, ours is the first documented case of synchronous primary incidental occurrence of Invasive Ductal Carcinoma (IDC) and Renal Cell Carcinoma (RCC) in a Middle Eastern male. This type of co-occurrence must be borne in mind because such neoplastic occurrence is potentially fatal. Documentation is essential to raise awareness and to decrease the resultant morbidity and mortality.
We present a case of a 61-year-old male who presented to our clinic with a 22-day-history of gradual, painless, and disproportionate hypertrophy of his left breast. CT scan revealed incidental breast and right kidney masses. Therapeutic intervention included a modified radical mastectomy with Sentinel lymph node excision along with right radical nephrectomy.
Treatment of our patient was multimodal. Accurate radiological studying together with clinical examination helped us in making a diagnosis. Treatment options for this pathology consist of a combination of surgery and/or adjuvant therapy.
Synchronous IDC and RCC are an extremely rare co-occurrence, especially in males, particularly Middle Eastern males, and more specifically, those presenting asymptomatically as incidental findings. It is vital to further document and study such cases to establish innovative surgical techniques, screening modalities for males, and to overcome the consequential morbidity and mortality.
同步性恶性肿瘤被定义为一个或多个肿瘤同时出现或在彼此6个月内出现。50岁以上人群最为易感。同步性肿瘤形成的记录患病率为4.5%-11.7%。据我们所知,我们的病例是中东男性中首例记录在案的同步原发性偶发性浸润性导管癌(IDC)和肾细胞癌(RCC)。必须牢记这种共发情况,因为这种肿瘤发生可能是致命的。记录对于提高认识以及降低由此导致的发病率和死亡率至关重要。
我们报告一例61岁男性患者,他因左侧乳房逐渐出现、无痛且不成比例的肥大22天前来我院就诊。CT扫描显示乳房和右肾有偶发性肿块。治疗干预包括改良根治性乳房切除术加前哨淋巴结切除以及右根治性肾切除术。
我们患者的治疗是多模式的。准确的影像学检查和临床检查有助于我们做出诊断。这种病理情况的治疗选择包括手术和/或辅助治疗的联合应用。
同步性IDC和RCC同时出现极为罕见,尤其是在男性中,特别是中东男性,更具体地说,是那些无症状作为偶发发现的患者。进一步记录和研究此类病例对于建立创新的手术技术、男性筛查模式以及克服随之而来的发病率和死亡率至关重要。